medicine-news-1/service-corporation-international-announces-schedule-for-its-second-quarter-2009-earnings-release-and-conference-call-52397-2/;msg90356

Navigation LinksBiology News Health News Biology Technology Medicine Technology

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

We're sorry, that page (http://www.bio-medicine.org/medicine-news-1/service-corporation-international-announces-schedule-for-its-second-quarter-2009-earnings-release-and-conference-call-52397-2/;msg90356) was not found.

Search medicine news 1 service corporation international announces schedule for its second quarter 2009 earnings release and conference call 52397 2 ;msg90356 at Google

Search medicine news 1 service corporation international announces schedule for its second quarter 2009 earnings release and conference call 52397 2 ;msg90356 at Yahoo

Search medicine news 1 service corporation international announces schedule for its second quarter 2009 earnings release and conference call 52397 2 ;msg90356 at Msn

Breaking Biology News(10 mins):Oceans day at International Climate Change Conference 2 ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 2 ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 3 ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 4 National Quality Forum Endorses Six Measures for Melanoma and Eye Care 60767 1 National Quality Forum Endorses Six Measures for Melanoma and Eye Care 60767 2 ChemSW Rated Top Vendor Overall for Customer Satisfaction in Q3 2009 by VendorRate 60765 1 ChemSW Rated Top Vendor Overall for Customer Satisfaction in Q3 2009 by VendorRate 60765 2 Working Parents Take the Panic Out of Flu Pandemic 60763 1 Working Parents Take the Panic Out of Flu Pandemic 60763 2

[0] Oceans day at International Climate Change Conference [0] NFL grant to strengthen knee research [0] ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER

Breaking Medicine News(10 mins):Health News:Nutraceutical Reports Fiscal 2009 Year End Results 2 Health News:Nutraceutical Reports Fiscal 2009 Year End Results 3 Health News:Nutraceutical Reports Fiscal 2009 Year End Results 4 Health News:Nutraceutical Reports Fiscal 2009 Year End Results 5 Health News:Nutraceutical Reports Fiscal 2009 Year End Results 6 Health News:Nutraceutical Reports Fiscal 2009 Year End Results 7 Health News:Nutraceutical Reports Fiscal 2009 Year End Results 8 Health News:Study highlights lack of patient knowledge regarding hospital medications 2 Health News:Nonprofit Partners With PR Company and Gains International Attention 2

[0] Nutraceutical Reports Fiscal 2009 Year End Results [0] Algeos Launches UK's First Private Podiatrist Loyalty Program [0] Study highlights lack of patient knowledge regarding hospital medications [0] Nonprofit Partners With PR Company and Gains International Attention [1] Amilpar - Relevant Fact - Public Offer

Biology Products:

Rat Anti-Rat RT1Au (Class I Polymorphic) Monoclonal Antibody, Unconjugated from AbD Serotec Mouse Anti-Simian Virus 5 Monoclonal Antibody, Unconjugated from AbD Serotec Dog Serum-Mixed Breed from Innovative Research X-Gal/IPTG Solution from Bioline

Medicine Products:

Gehrung Pessary Shaatz Pessary CardioVive AT AED BioArc™ TO Subfascial Hammock

Breaking Biology Technology:BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 2 BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 3 Oxford BioTherapeutics Appoints Michael Moore as Chairman 2 Oxford BioTherapeutics Appoints Michael Moore as Chairman 3 Oxford BioTherapeutics Appoints Michael Moore as Chairman 4 Dendreon Announces Proposed Public Offering of Common Stock 2 Dendreon Announces Proposed Public Offering of Common Stock 3 Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property 2

[0] BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes [0] Oxford BioTherapeutics Appoints Michael Moore as Chairman [0] Dendreon Announces Proposed Public Offering of Common Stock [0] Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property

Breaking Medicine Technology:Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2 Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3 Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4 Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5 FDA Launches Orphan Drug Workshop at KGI 2 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6 Companion Life Adds Dental Tourism Option to Help Policyholders Save 60761 1 Companion Life Adds Dental Tourism Option to Help Policyholders Save 60761 2 Companion Life Adds Dental Tourism Option to Help Policyholders Save 60761 3 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 1 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 2 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 3 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 4 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 5 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 6 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 7 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 8 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 9 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 10 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 11 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 12 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 13 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 14 SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 14733 1 SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 14733 2

[0] Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs [0] FDA Launches Orphan Drug Workshop at KGI [0] Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium